Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8U4U

Crystal structure of 53BP1 tandem Tudor domain homodimer engineered with two disulfide bridges

8U4U の概要
エントリーDOI10.2210/pdb8u4u/pdb
関連するPDBエントリー6MXX 6MXY 6MXZ 6MY0
分子名称TP53-binding protein 1 (1 entity in total)
機能のキーワード53bp1, dna damage response, dna double-strand break repair, non-homologous end joining, homologous recombination, chromatin-binding protein, engineered protein, signaling protein
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数10
化学式量合計140470.06
構造登録者
Cui, G.,Botuyan, M.V.,Thompson, J.R.,Mer, G. (登録日: 2023-09-11, 公開日: 2023-09-20, 最終更新日: 2024-10-16)
主引用文献Cui, G.,Botuyan, M.V.,Drane, P.,Hu, Q.,Bragantini, B.,Thompson, J.R.,Schuller, D.J.,Detappe, A.,Perfetti, M.T.,James, L.I.,Frye, S.V.,Chowdhury, D.,Mer, G.
An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering.
Nat Commun, 14:6091-6091, 2023
Cited by
PubMed Abstract: The recruitment of 53BP1 to chromatin, mediated by its recognition of histone H4 dimethylated at lysine 20 (H4K20me2), is important for DNA double-strand break repair. Using a series of small molecule antagonists, we demonstrate a conformational equilibrium between an open and a pre-existing lowly populated closed state of 53BP1 in which the H4K20me2 binding surface is buried at the interface between two interacting 53BP1 molecules. In cells, these antagonists inhibit the chromatin recruitment of wild type 53BP1, but do not affect 53BP1 variants unable to access the closed conformation despite preservation of the H4K20me2 binding site. Thus, this inhibition operates by shifting the conformational equilibrium toward the closed state. Our work therefore identifies an auto-associated form of 53BP1-autoinhibited for chromatin binding-that can be stabilized by small molecule ligands encapsulated between two 53BP1 protomers. Such ligands are valuable research tools to study the function of 53BP1 and have the potential to facilitate the development of new drugs for cancer therapy.
PubMed: 37773238
DOI: 10.1038/s41467-023-41821-6
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.79 Å)
構造検証レポート
Validation report summary of 8u4u
検証レポート(詳細版)ダウンロードをダウンロード

227561

件を2024-11-20に公開中

PDB statisticsPDBj update infoContact PDBjnumon